Position in ALXO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$25,833,699
+$14,872,784 QoQ
Shares Held
12,884,638
+32.8% QoQ
Ownership
9.58%
of shares outstanding
% of Portfolio
9.21%
of 13F equity value
Holder Rank
#3
of 68 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026venBio Partners LLC holds $280,553,199 across 6 Biotechnology names. ALXO ranks #3 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PHVS |
Pharvaris N.V.
|
4,639,304 | $131,060,338 | |
| 2 | ALMS |
Alumis Inc.
|
4,528,408 | $99,760,828 | |
| 3 | ALXO |
Alx Oncology Holdings Inc
This page
|
12,884,638 | $25,833,699 | |
| 4 | HRMY |
Harmony Biosciences Holdings, Inc.
|
489,194 | $13,702,323 | |
| 5 | LYEL |
Lyell Immunopharma, Inc.
|
337,697 | $6,774,201 | |
| 6 | ARTV |
Artiva Biotherapeutics, Inc.
|
531,337 | $3,421,810 |
All Filings in ALXO
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,833,699 | 12,884,638 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,960,915 | 9,699,925 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,750,862 | 9,699,925 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,025,468 | 9,699,925 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,043,053 | 9,699,925 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,198,874 | 9,699,925 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,653,863 | 9,699,925 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $58,490,547 | 9,699,925 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $108,154,163 | 9,699,925 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $144,431,883 | 9,699,925 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $46,559,640 | 9,699,925 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $72,846,436 | 9,699,925 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $43,843,661 | 9,699,925 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $109,318,154 | 9,699,925 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $92,828,282 | 9,699,925 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $78,472,393 | 9,699,925 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $163,928,732 | 9,699,925 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $208,451,388 | 9,699,925 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $716,436,460 | 9,699,925 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $530,391,899 | 9,699,925 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $715,272,469 | 9,699,925 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $836,133,535 | 9,699,925 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $366,075,169 | 9,699,925 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||